We are excited to announce that Scinetics is partnering with Nucleate’s Global Virtual Activator (GVA) to support a new generation of life science researchers and biotech founders around the world.
About Nucleate GVA
Nucleate is a global nonprofit organization led by students and early-career researchers, helping scientists translate frontier discoveries into biotechnology ventures.
Its flagship Activator is one of the world’s largest student-led biotech venture programs. It is free and takes no equity, connecting early-stage founders with industry mentors, entrepreneurial training, team formation support, and a global network of operators and investors.
The Global Virtual Activator removes geographic barriers, allowing young researchers and founders from around the world to participate remotely in this ecosystem.
About Scinetics and STELLA
At Scinetics, we are developing AI for Science foundation models, research agents, and automated experimental systems, initially focused on the life sciences. Our first foundation model focuses on the path from DNA to RNA to protein and function.
STELLA (BioClaw), our self-evolving AI research agent, helps researchers tackle complex scientific problems through AI-driven reasoning, scientific tool orchestration, and multi-step research workflows—from literature analysis and hypothesis generation to experimental design.
STELLA has already supported more than 1,000 researchers across universities and research institutions worldwide.
Supporting the GVA 2026–27 cohort
Through this partnership, Scinetics will provide free STELLA access to every team selected for the GVA 2026–27 cohort, helping early-stage biotech ventures explore practical applications of AI across research and product development.
For qualifying teams, we will also explore reviewed local deployment options to support more flexible scientific workflows.
GVA teams can apply directly through STELLA. Please include “GVA team” in the application remarks, and we will prioritize your application for review.
APPLICATIONS
GVA 2026–27 is now recruiting.
Students, PhD candidates, postdoctoral researchers, and early-career scientists with an early-stage biotech idea and a scientific foundation are encouraged to apply—even if they have not yet incorporated a company.
Application deadline: October 20, 2026
From ideas to discovery
By connecting GVA’s global community of life science founders with Scinetics’ AI platform, we hope to unlock new opportunities for AI-driven scientific discovery—and accelerate the journey from scientific ideas to real-world discoveries.
Accelerating Discovery Together.